Healthcare - Biotechnology - NASDAQ - US
$ 4.2
-0.474 %
$ 13.5 M
Market Cap
-0.1
P/E
INCOME STATEMENT
0
REVENUE
-22.8 M
OPERATING INCOME
-23.5 K
NET INCOME
EFFICIENCY
Earnings Waterfall
Cingulate Inc.
| Revenue | 0 |
| Cost Of Revenue | 583 K |
| Gross Profit | -583 K |
| Operating Expenses | 22.8 M |
| Operating Income | -22.8 M |
| Other Expenses | -22.7 M |
| Net Income | -23.5 K |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 0.6 | 0.6 | 0.8 | 0.8 | 0.2 |
| Gross Profit | (0.6) | (0.6) | (0.8) | (0.8) | (0.2) |
| OPERATING INCOME | |||||
| Operating Expenses | 22.8 | 17.5 | 20.7 | 7.1 | 11.6 |
| Selling, General and Administrative Expenses | 6.7 | 8.5 | 12.3 | 2.0 | 2.6 |
| Research and Development Expenses | 15.5 | 9.0 | 8.4 | 5.1 | 9.1 |
| Operating Income | (22.8) | (17.5) | (20.7) | (7.1) | (11.6) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | (0.8) | 0.2 | 437 | 54.6 K | 0 |
| Total Other Income | (0.8) | (0.2) | 30.6 K | (0.1) | 0.1 |
| Pre-Tax Income | (23.5) | (17.7) | (20.7) | (7.2) | (11.5) |
| NET INCOME | |||||
| Tax Provision | 0 | 0.2 | 30.5 K | 99.3 K | (0.1) |
| Net Income | (23.5) | (17.9) | (20.7) | (7.3) | (11.4) |
| EPS | 26 | 29.6 | 36.7 | 12.9 | 0.0108 |